Harvard Bioscience Secures $40 Million Credit Facility from BroadOak Capital Partners
Harvard Bioscience Inc. has announced the successful completion of a new $40 million credit facility agreement with BroadOak Capital Partners, a life-sciences-focused investment and advisory firm. The financing package consists of three term loans, all funded on December 17, 2025, and will be used to retire the company's existing debt obligations, improve its balance sheet, and enhance financial flexibility. Guggenheim Securities acted as lead financial advisor to Harvard Bioscience on the transaction, with Covington & Burling LLP and Cooley LLP serving as legal advisors to Harvard Bioscience and BroadOak, respectively. As part of the agreement, Bill Snider, Partner at BroadOak, will join Harvard Bioscience's Board of Directors, and the company will form a new advisory board focused on growth and operational opportunities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9603465-en) on December 17, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.